Category: News

Avista Capital Partners to Acquire Probo Medical

New York, NY and Tampa, FL — February 15, 2022 — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, and Probo Medical, LLC (“Probo” or “the Company”) today announced that Avista has entered into definitive documentation to acquire Probo from Varsity Healthcare Partners.  Transaction terms were not disclosed. Founded in […]

Written by on February 15, 2022

Private Equity Industry’s First-Ever ESG Data Convergence Project Announces Milestone Commitment of Over 100 LPs and GPs

Global LPs and GPs representing $8.7 trillion USD in AUM and more than 1,400 private companies commit to collaborative ESG reporting system in its inaugural year January 28th, 2022 – Since its launch in September 2021, the ESG Data Convergence Project, which seeks to standardize ESG metrics and provide a mechanism for comparative reporting for […]

Written by on January 28, 2022

Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance

  BRIDGEWATER, N.J., Jan. 19, 2022 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“OSMT” or the “Company”), a specialty pharmaceutical company, announced today that the Company has changed its name to RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL”). This rebranding reflects RVL’s strategy to become a growth company in eye care and medical aesthetics, and, […]

Written by on January 26, 2022

Cosette Pharmaceuticals Acquires Rights to Eight Branded Products from Daiichi Sankyo

Transformational Transaction Diversifies Cosette’s Business to Accelerate Future Growth BRIDGEWATER, NJ – JANUARY 18, 2022: Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, announced today that it has closed a transaction to acquire the US sales and distribution rights to eight branded commercial products from leading Japanese pharmaceutical company, Daiichi Sankyo Company, Ltd (4568:JP) and […]

Written by on January 18, 2022

Avista Capital Partners Announces Promotions

Amanda Heravi, Ben Silbert, and John Cafasso to Become Managing Directors Anthony Russo to Assume Role of Director, Accounting and Operations NEW YORK, January 5, 2022 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced a series of promotions of key members of its business management team. Effective January […]

Written by on January 4, 2022

XIFIN Expands into Pharmacy Market with Acquisition of OmniSYS

Transaction supports healthcare industry shift to more convenient, cost-effective care settings; provides technology-driven connection between pharmacies, diagnostic providers, and payors San Diego, Calif. – December 14, 2021 – XIFIN today announced the strategic acquisition of OmniSYS, a leading provider of technology solutions for the retail pharmacy industry. Building on the acquisition of Computerized Management Services in July 2021, this transaction […]

Written by on December 14, 2021

Avista Capital Becomes Signatory to United Nations Principles for Responsible Investment

NEW YORK, Dec. 13, 2021 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that it has become a signatory to the United Nations-supported Principles for Responsible Investment (PRI), joining the leading international network of institutional investors committed to developing a more sustainable global financial system. The Principles for Responsible […]

Written by on December 13, 2021

Vision Healthcare announces the acquisition of Vitamaze GmbH, a leading European vitamins, minerals & nutritional supplements (“VMS”) e-commerce player, predominantly active through Amazon marketplaces and e-pharma channels

Kortrijk (Belgium), 26 November 2021 About the Acquisition Vision Healthcare reached an agreement with the shareholder of Vitamaze GmbH for the acquisition of 100% of the shares in Vitamaze GmbH (“Vitamaze” or the “Company”), a leading European e-commerce player active in the vitamins and nutritional supplements markets mainly through Amazon across Europe and e-pharma. Vitamaze […]

Written by on November 26, 2021

Cooper Consumer Health announces the appointment of Bart Meermans as CEO and the acquisition of Lashilé Beauty

Paris, France, November 8, 2021 — Cooper Consumer Health (“Cooper”) a leading European independent over-the-counter drug manufacturer and distributor, is pleased to announce the appointment of Bart Meermans as its new Chief Executive Officer and the agreement to acquire French consumer health food supplement business, Lashilé Beauty. Bart Meermans has a wealth of industry experience […]

Written by on November 8, 2021

Avista Capital Partners and Nordic Capital to sell Acino, a leader in advanced drug delivery technologies, to ADQ

— Ownership period defined by Acino’s transformation and growth to become leading provider of trusted and innovative pharmaceuticals in emerging markets — New York, NY and Zurich, September 16, 2021 — Leading healthcare investors Avista Capital Partners (“Avista Capital”) and Nordic Capital (through Nordic Capital CV1) today announced that they have entered into a definitive […]

Written by on September 16, 2021

Avista Capital Partners Completes Sale of Arcadia Consumer Healthcare

NEW YORK, Sept. 10, 2021 — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced the completion of its sale of Arcadia Consumer Healthcare, Inc. (“Arcadia”), a recognized leader in the consumer healthcare market for over-the-counter (“OTC”) medicines and premium vitamins and nutritional supplements, to Bansk Group. The transaction was first announced […]

Written by on September 10, 2021

Osmotica Pharmaceuticals plc Closes Sale of Legacy Business to Alora Pharmaceuticals, LLC

— Divestiture advances Company’s transformation and emphasis on eye care and ocular aesthetics — — Proceeds of the sale will be used to retire a substantial portion of outstanding debt — BRIDGEWATER, N.J., Aug. 30, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that […]

Written by on August 30, 2021